Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT07266805

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema…

This is a Phase 3, multicenter, 3-part study, with 2 randomized, double-blind, placebo-controlled parts and an open-label extension part, to evaluate the effica…

United States, Bulgaria, Canada32 participantsStarted 2025-10-16

Treatment: Deucrictibant, Placebo

Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant IR Capsule for On-Demand Treatment of Angioedema…

All recent trials (1 shown)